Cargando…
2236. Direct-Acting Antivirals: Efficacy in a Real-World, Urban, Undeserved, HIV-HCV Co-Infected Population
BACKGROUND: Clinical trials demonstrated high sustained virologic response (SVR) rates for HIV-HCV co-infected patients treated for HCV with direct-acting antivirals (DAAs). SVR data for real-world cohorts are increasingly available, yet limited in underserved populations. Individual and systematic...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252421/ http://dx.doi.org/10.1093/ofid/ofy210.1889 |